Andersohn Frank, Schade René, Suissa Samy, Garbe Edeltraut
Bremen Institute for Prevention Research and Social Medicine, Bremen, Germany.
Am J Psychiatry. 2009 May;166(5):591-8. doi: 10.1176/appi.ajp.2008.08071065. Epub 2009 Apr 1.
Use of antidepressants has been reported to cause considerable weight gain. The aim of this study was to assess the risk of diabetes mellitus associated with antidepressant treatment and to examine whether the risk is influenced by treatment duration or daily dose.
This was a nested case-control study in a cohort of 165,958 patients with depression who received at least one new prescription for an antidepressant between January 1, 1990, and June 30, 2005. Data were from from the U.K. General Practice Research Database. Patients were at least 30 years of age and without diabetes at cohort entry.
A total of 2,243 cases of incident diabetes mellitus and 8,963 matched comparison subjects were identified. Compared with no use of antidepressants during the past 2 years, recent long-term use (>24 months) of antidepressants in moderate to high daily doses was associated with an increased risk of diabetes (incidence rate ratio=1.84, 95% CI=1.35-2.52). The magnitude of the risk was similar for long-term use of moderate to high daily doses of tricyclic antidepressants (incidence rate ratio=1.77, 95% CI=1.21-2.59) and selective serotonin reuptake inhibitors (incidence rate ratio=2.06, 95% CI=1.20-3.52). Treatment for shorter periods or with lower daily doses was not associated with an increased risk.
Long-term use of antidepressants in at least moderate daily doses was associated with an increased risk of diabetes. This association was observed for both tricyclic antidepressants and selective serotonin reuptake inhibitors.
据报道,使用抗抑郁药会导致显著体重增加。本研究的目的是评估与抗抑郁药治疗相关的糖尿病风险,并研究该风险是否受治疗持续时间或每日剂量的影响。
这是一项巢式病例对照研究,队列包括165958名抑郁症患者,他们在1990年1月1日至2005年6月30日期间至少接受过一次抗抑郁药新处方。数据来自英国全科医疗研究数据库。患者在队列入组时年龄至少30岁且无糖尿病。
共识别出2243例新发糖尿病病例和8963名匹配的对照对象。与过去2年未使用抗抑郁药相比,近期长期(>24个月)使用中至高每日剂量抗抑郁药与糖尿病风险增加相关(发病率比=1.84,95%可信区间=1.35 - 2.52)。长期使用中至高每日剂量的三环类抗抑郁药(发病率比=1.77,95%可信区间=1.21 - 2.59)和选择性5-羟色胺再摄取抑制剂(发病率比=2.06,95%可信区间=1.20 - 3.52)的风险程度相似。较短疗程或较低每日剂量治疗与风险增加无关。
至少长期使用中等剂量抗抑郁药与糖尿病风险增加相关。三环类抗抑郁药和选择性5-羟色胺再摄取抑制剂均观察到这种关联。